NMDA receptor subunits have different roles in NMDA-induced neurotoxicity in the retina

Molecular Brain

Volumn 6, Issue 1, 2013, Pages

  Bai, Ning ^a,c   Aida, Tomomi ^a   Yanagisawa, Michiko ^a   Katou, Sayaka ^a   Sakimura, Kenji ^d   Mishina, Masayoshi ^e   Tanaka, Kohichi ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

^d NIIGATA UNIVERSITY   (Japan)

^e RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

Excitotoxicity; Glaucoma; GluN2B; GluN2D; Glutamate transporter; NMDA receptor; Retina

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; 7-HYDROXY-6-METHOXY-2-METHYL-1-(2-(4-(TRIFLUOROMETHYL)PHENYL)ETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE; EXCITATORY AMINO ACID TRANSPORTER 1; ISOQUINOLINE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYLASPARTIC ACID; NEUROTOXIN; PROTEIN SUBUNIT; SLC1A3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CONTROLLED STUDY; EXCITOTOXICITY; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA GANGLION CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; DEFICIENCY; DRUG EFFECTS; GENE DELETION; METABOLISM; NICK END LABELING; PATHOLOGY; PROTEIN SUBUNIT; TOXICITY;

MUS;

ANIMALS; CELL DEATH; EXCITATORY AMINO ACID TRANSPORTER 1; GENE DELETION; IN SITU NICK-END LABELING; ISOQUINOLINES; MICE; N-METHYLASPARTATE; NEUROTOXINS; PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE; RETINA;

EID: 84880878310     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-6-34     Document Type: Article

References (43)

1. Glutamate neurotoxicity and diseases of the nervous system. Choi DW, Neuron 1988 1 623 634 10.1016/0896-6273(88)90162-6 2908446
2. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Choi DW, Rothman SM, Annu Rev Neurosci 1990 13 171 182 10.1146/annurev.ne.13. 030190.001131 1970230 (Pubitemid 20100647)
3. Glutamate and epilepsy. Chapman AG, J Nutr 2000 130 4S Suppl 1043S 1045S 10736378 (Pubitemid 30173641)
4. Amino acids as dietary excitotoxins: a contribution to understanding neurodegenerative disorders. Meldrum B, Brain Res Brain Res Rev 1993 18 293 314 10.1016/0165-0173(93)90014-Q 8401596 (Pubitemid 23219501)
5. NMDA receptors in clinical neurology: excitatory times ahead. Kalia LV, Kalia SK, Salter MW, Lancet Neurol 2008 7 742 755 10.1016/S1474-4422(08)70165-0 18635022 (Pubitemid 351957932)
6. Possible role of excitotoxicity in the pathogenesis of glaucoma. Casson RJ, Clin Experiment Ophthalmol 2006 34 54 63 10.1111/j.1442-9071.2006.01146.x 16451260 (Pubitemid 43379371)
7. Hypoxia-ischemia and retinal ganglion cell damage. Kaur C, Foulds WS, Ling EA, Clin Ophthalmol 2008 2 879 889 19668442
8. Neuroprotection in diabetic retinopathy. Hernández C, Simó R, Curr Diab Rep 2012 12 329 337 10.1007/s11892-012-0284-5 22581259
9. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Honkanen RA, Baruah S, Zimmerman MB, Khanna CL, Weaver YK, Narkiewicz J, Waziri R, Gehrs KM, Weingeist TA, Boldt HC, et al. Arch Ophthalmol 2003 121 183 188 10.1001/archopht.121.2.183 12583783 (Pubitemid 36184030)
10. Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection. Levkovitch-Verbin H, Martin KR, Quigley HA, Baumrind LA, Pease ME, Valenta D, J Glaucoma 2002 11 396 405 10.1097/00061198-200210000-00005 12362078
11. Vitreal glutamate concentration in monkeys with experimental glaucoma. Carter-Dawson L, Crawford ML, Harwerth RS, Smith EL, Feldman R, Shen FF, Mitchell CK, Whitetree A, Invest Ophthalmol Vis Sci 2002 43 2633 2637 12147596 (Pubitemid 34809453)
12. Ca2+ influx through glutamate receptor-associated channels in retina cells correlates with neuronal cell death. Ferreira IL, Duarte CB, Carvalho AP, Eur J Pharmacol 1996 302 153 162 10.1016/0014-2999(96)00044-1 8791003
13. NMDA receptor subunits: diversity, development and disease. Cull-Candy S, Brickley S, Farrant M, Curr Opin Neurobiol 2001 11 327 335 10.1016/S0959- 4388(00)00215-4 11399431 (Pubitemid 32524098)
14. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. Harada T, Harada C, Nakamura K, Quah HM, Okumura A, Namekata K, Saeki T, Aihara M, Yoshida H, Mitani A, et al. J Clin Invest 2007 117 1763 1770 10.1172/JCI30178 17607354 (Pubitemid 47036310)
15. Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity. Bai N, Hayashi H, Aida T, Namekata K, Harada T, Mishina M, Tanaka K, Mol Brain 2013 6 22 10.1186/1756-6606-6-22 23641686
16. In vitro and antinociceptive profile of HON0001, an orally active NMDA receptor NR2B subunit antagonist. Suetake-Koga S, Shimazaki T, Takamori K, Chaki S, Kanuma K, Sekiguchi Y, Suzuki T, Kikuchi T, Matsui Y, Honda T, Pharmacol Biochem Behav 2006 84 134 141 10.1016/j.pbb.2006.04.018 16764916 (Pubitemid 43975558)
17. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR, Neuron 2000 28 41 51 10.1016/S0896-6273(00)00084-2 11086982
18. Brn-3b: a POU domain gene expressed in a subset of retinal ganglion cells. Xiang M, Zhou L, Peng YW, Eddy RL, Shows TB, Nathans J, Neuron 1993 11 689 701 10.1016/0896-6273(93)90079-7 7691107 (Pubitemid 23321777)
19. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y, Sugiyama H, Nature 1995 373 151 155 10.1038/373151a0 7816096
20. Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunit. Kadotani H, Hirano T, Masugi M, Nakamura K, Nakao K, Katsuki M, Nakanishi S, J Neurosci 1996 16 7859 7867 8987814 (Pubitemid 26405049)
21. Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel. Ikeda K, Araki K, Takayama C, Inoue Y, Yagi T, Aizawa S, Mishina M, Brain Res Mol Brain Res 1995 33 61 71 10.1016/0169-328X(95) 00107-4 8774946
22. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Kutsuwada T, Sakimura K, Manabe T, Takayama C, Katakura N, Kushiya E, Natsume R, Watanabe M, Inoue Y, Yagi T, et al. Neuron 1996 16 333 344 10.1016/S0896-6273(00)80051-3 8789948
23. NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses. Akashi K, Kakizaki T, Kamiya H, Fukaya M, Yamasaki M, Abe M, Natsume R, Watanabe M, Sakimura K, J Neurosci 2009 29 10869 10882 10.1523/JNEUROSCI.5531-08.2009 19726645
24. Functional expression of Cre recombinase in sub-regions of mouse CNS and retina. Eriksson B, Bergqvist I, Eriksson M, Holmberg D, FEBS Lett 2000 479 106 110 10.1016/S0014-5793(00)01893-7 10981716 (Pubitemid 30616415)
25. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, et al. Nat Neurosci 2010 13 133 140 10.1038/nn.2467 20023653
26. Pronounced cell death in the absence of NMDA receptors in the developing somatosensory thalamus. Adams SM, de Rivero Vaccari JC, Corriveau RA, J Neurosci 2004 24 9441 9450 10.1523/JNEUROSCI.3290-04.2004 15496680 (Pubitemid 39426180)
27. Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse. Endo K, Nakamachi T, Seki T, Kagami N, Wada Y, Nakamura K, Kishimoto K, Hori M, Tsuchikawa D, Shinntani N, et al. J Mol Neurosci 2011 43 22 29 10.1007/s12031-010-9434-x 20703829
28. Dock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma. Namekata K, Kimura A, Kawamura K, Guo X, Harada C, Tanaka K, Harada T, Cell Death Differ 2013 10.1038/cdd.2013.91
29. A potential neuroprotective role of apolipoprotein E-containing lipoproteins through low density lipoprotein receptor-related protein 1 in normal tension glaucoma. Hayashi H, Eguchi Y, Fukuchi-Nakaishi Y, Takeya M, Nakagata N, Tanaka K, Vance JE, Tanihara H, J Biol Chem 2012 287 25395 25406 10.1074/jbc.M112.370130 22674573
30. alpha 2-Macroglobulin exposure reduces calcium responses to N-methyl-D-aspartate via low density lipoprotein receptor-related protein in cultured hippocampal neurons. Qiu Z, Strickland DK, Hyman BT, Rebeck GW, J Biol Chem 2002 277 14458 14466 10.1074/jbc.M112066200 11839752 (Pubitemid 34952510)
31. The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors. Martin AM, Kuhlmann C, Trossbach S, Jaeger S, Waldron E, Roebroek A, Luhmann HJ, Laatsch A, Weggen S, Lessmann V, et al. J Biol Chem 2008 283 12004 12013 10.1074/jbc.M707607200 18321860
32. Expression of mRNA for glutamate receptor subunits distinguishes the major classes of retinal neurons, but is less specific for individual cell types. Jakobs TC, Ben Y, Masland RH, Mol Vis 2007 13 933 948 17653033 (Pubitemid 46957325)
33. The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults. Martel MA, Ryan TJ, Bell KF, Fowler JH, McMahon A, Al-Mubarak B, Komiyama NH, Horsburgh K, Kind PC, Grant SG, et al. Neuron 2012 74 543 556 10.1016/j.neuron.2012.03.021 22578505
34. Evolution of NMDA receptor cytoplasmic interaction domains: implications for organisation of synaptic signalling complexes. Ryan TJ, Emes RD, Grant SG, Komiyama NH, BMC Neurosci 2008 9 6 10.1186/1471-2202-9-6 18197970 (Pubitemid 351315041)
35. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Hardingham GE, Bading H, Nat Rev Neurosci 2010 11 682 696 10.1038/nrn2911 20842175
36. Subunit- and pathway-specific localization of NMDA receptors and scaffolding proteins at ganglion cell synapses in rat retina. Zhang J, Diamond JS, J Neurosci 2009 29 4274 4286 10.1523/JNEUROSCI.5602-08.2009 19339621
37. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vöckler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW, Science 1999 283 70 74 10.1126/science.283.5398.70 9872743 (Pubitemid 29044848)
38. Differential distributions of the NMDA receptor channel subunit mRNAs in the mouse retina. Watanabe M, Mishina M, Inoue Y, Brain Res 1994 634 328 332 10.1016/0006-8993(94)91938-0 7510577 (Pubitemid 24025065)
39. Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Harada T, Harada C, Watanabe M, Inoue Y, Sakagawa T, Nakayama N, Sasaki S, Okuyama S, Watase K, Wada K, et al. Proc Natl Acad Sci USA 1998 95 4663 4666 10.1073/pnas.95.8.4663 9539795 (Pubitemid 28207970)
40. Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice. Watase K, Hashimoto K, Kano M, Yamada K, Watanabe M, Inoue Y, Okuyama S, Sakagawa T, Ogawa S, Kawashima N, et al. Eur J Neurosci 1998 10 976 988 10.1046/j.1460-9568.1998.00108.x 9753165 (Pubitemid 28375622)
41. Selective scarcity of NMDA receptor channel subunits in the stratum lucidum (mossy fibre-recipient layer) of the mouse hippocampal CA3 subfield. Watanabe M, Fukaya M, Sakimura K, Manabe T, Mishina M, Inoue Y, Eur J Neurosci 1998 10 478 487 10.1046/j.1460-9568.1998.00063.x 9749710 (Pubitemid 28325471)
42. Target-cell-specific left-right asymmetry of NMDA receptor content in schaffer collateral synapses in epsilon1/NR2A knock-out mice. Wu Y, Kawakami R, Shinohara Y, Fukaya M, Sakimura K, Mishina M, Watanabe M, Ito I, Shigemoto R, J Neurosci 2005 25 9213 9226 10.1523/JNEUROSCI.2134-05.2005 16207881 (Pubitemid 41500830)
43. Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Chi ZL, Akahori M, Obazawa M, Minami M, Noda T, Nakaya N, Tomarev S, Kawase K, Yamamoto T, Noda S, et al. Hum Mol Genet 2010 19 2606 2615 10.1093/hmg/ddq146 20388642